Determination of the drug binding site within integrin CD11b/CD18
Keith Rands, Darren G. Stoub, Vineet Gupta
Abstract
Keith Rands, Darren G. Stoub, Vineet Gupta
Abstract
α/β integrin heterodimers are cell surface proteins involved in cellular communication. The integrin CD11b/CD18 is the predominant integrin found in neutrophils, macrophages and monocoytes and has been implicated as a signaling protein for the inflammation response. Recently, a class of small molecule drugs that activate the integrin CD11b/CD18 was reported. Using molecular docking experiments and site‐directed mutagenesis, we have identified a putative drug binding site in the ligand‐binding aA domain of CD11b, which suggest an allosteric activation of the integrin.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
α/β integrin heterodimers are cell surface proteins involved in cellular communication. The integrin CD11b/CD18 is the predominant integrin found in neutrophils, macrophages and monocoytes and has been implicated as a signaling protein for the inflammation response. Recently, a class of small molecule drugs that activate the integrin CD11b/CD18 was reported. Using molecular docking experiments and site‐directed mutagenesis, we have identified a putative drug binding site in the ligand‐binding aA domain of CD11b, which suggest an allosteric activation of the integrin.
Key concepts: Integrin alpha M, CD18, Integrin, Allosteric regulation, Integrin, beta 6, Cell biology, Chemistry, Binding site